- Home
- EPWK vs ADTX Comparison
EPWK vs ADTX Comparison
Compare EPWK & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- ADTX
- Stock Information
- Founded
- EPWK 2011
- ADTX 2017
- Country
- EPWK China
- ADTX United States
- Employees
- EPWK N/A
- ADTX N/A
- Industry
- EPWK
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- EPWK
- ADTX Health Care
- Exchange
- EPWK Nasdaq
- ADTX Nasdaq
- Market Cap
- EPWK 1.3M
- ADTX 1.1M
- IPO Year
- EPWK 2025
- ADTX 2020
- Fundamental
- Price
- EPWK $1.43
- ADTX $3.01
- Analyst Decision
- EPWK
- ADTX
- Analyst Count
- EPWK 0
- ADTX 0
- Target Price
- EPWK N/A
- ADTX N/A
- AVG Volume (30 Days)
- EPWK 4.8M
- ADTX 200.5K
- Earning Date
- EPWK 10-24-2025
- ADTX 11-18-2025
- Dividend Yield
- EPWK N/A
- ADTX N/A
- EPS Growth
- EPWK N/A
- ADTX N/A
- EPS
- EPWK N/A
- ADTX N/A
- Revenue
- EPWK $20,164,008.00
- ADTX $5,945.00
- Revenue This Year
- EPWK N/A
- ADTX $15,768.94
- Revenue Next Year
- EPWK N/A
- ADTX N/A
- P/E Ratio
- EPWK N/A
- ADTX N/A
- Revenue Growth
- EPWK 10.25
- ADTX N/A
- 52 Week Low
- EPWK $1.25
- ADTX $2.40
- 52 Week High
- EPWK $1,040.00
- ADTX $11,017.45
- Technical
- Relative Strength Index (RSI)
- EPWK 70.90
- ADTX 49.15
- Support Level
- EPWK $1.31
- ADTX $2.52
- Resistance Level
- EPWK $1.60
- ADTX $3.90
- Average True Range (ATR)
- EPWK 0.15
- ADTX 0.70
- MACD
- EPWK 0.11
- ADTX -0.36
- Stochastic Oscillator
- EPWK 70.74
- ADTX 16.92
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.